CD4+ T cells, particularly regulatory T cells (Tregs), can suppress CD8+ T-cell proliferation and cytotoxicity through inhibitory cytokines, IL-2 competition, and direct cell–cell contact, contributing to an immunosuppressive tumor microenvironment. The gene discussed is IL2; the disease is neoplasm.